These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8519417)

  • 21. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity.
    Gallardo D; Drazan KE; McBride WH
    Cancer Res; 1996 Nov; 56(21):4891-3. PubMed ID: 8895740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to genotoxic agents.
    Gangopadhyay S; Jalali F; Reda D; Peacock J; Bristow RG; Benchimol S
    Exp Cell Res; 2002 Apr; 275(1):122-31. PubMed ID: 11925110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent.
    Ogawa N; Fujiwara T; Kagawa S; Nishizaki M; Morimoto Y; Tanida T; Hizuta A; Yasuda T; Roth JA; Tanaka N
    Int J Cancer; 1997 Nov; 73(3):367-70. PubMed ID: 9359484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis.
    Kondo S; Barnett GH; Hara H; Morimura T; Takeuchi J
    Oncogene; 1995 May; 10(10):2001-6. PubMed ID: 7761100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
    Kawabe S; Munshi A; Zumstein LA; Wilson DR; Roth JA; Meyn RE
    Int J Radiat Biol; 2001 Feb; 77(2):185-94. PubMed ID: 11236925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.
    Kondo S; Barna BP; Kondo Y; Tanaka Y; Casey G; Liu J; Morimura T; Kaakaji R; Peterson JW; Werbel B; Barnett GH
    Oncogene; 1996 Sep; 13(6):1279-85. PubMed ID: 8808702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.
    Cai DW; Mukhopadhyay T; Liu Y; Fujiwara T; Roth JA
    Hum Gene Ther; 1993 Oct; 4(5):617-24. PubMed ID: 8280799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
    Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
    Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
    Li R; Sutphin PD; Schwartz D; Matas D; Almog N; Wolkowicz R; Goldfinger N; Pei H; Prokocimer M; Rotter V
    Oncogene; 1998 Jun; 16(25):3269-77. PubMed ID: 9681825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene.
    Inoue A; Narumi K; Matsubara N; Sugawara S; Saijo Y; Satoh K; Nukiwa T
    Cancer Lett; 2000 Aug; 157(1):105-12. PubMed ID: 10893449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors.
    Haas-Kogan DA; Kogan SS; Yount G; Hsu J; Haas M; Deen DF; Israel MA
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):399-403. PubMed ID: 10030268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro.
    Khalid MH; Shibata S; Hiura T
    J Neurosurg; 1999 May; 90(5):918-27. PubMed ID: 10223459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.
    Vasey PA; Jones NA; Jenkins S; Dive C; Brown R
    Mol Pharmacol; 1996 Dec; 50(6):1536-40. PubMed ID: 8967975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of wild-type p53 gene transfection on the growth and cisplatin sensitivity of cervical cancer cell line HeLa].
    Wang X; Peng Z; Wang H
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):40-2. PubMed ID: 12599424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines.
    Yee D; Hao C; Cheung HC; Chen HT; Dabbagh L; Hanson J; Coupland R; Petruk KC; Fulton D; Roa WH
    Clin Invest Med; 2001 Apr; 24(2):76-82. PubMed ID: 11368149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis.
    Cerrato JA; Yung WK; Liu TJ
    Neuro Oncol; 2001 Apr; 3(2):113-22. PubMed ID: 11296482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-induced apoptosis in melanoma cells is p53 dependent.
    Li G; Tang L; Zhou X; Tron V; Ho V
    Melanoma Res; 1998 Feb; 8(1):17-23. PubMed ID: 9508372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.